Q2 2026 Senzime AB (publ) Earnings Call Transcript
Key Points
- Senzime AB (SNZZF) reported a 15% decrease in operating expenses, demonstrating effective cost management.
- The company achieved a 27% improvement in EBITDA and a 46% improvement in cash flow, indicating strong financial performance despite a zero growth quarter.
- A significant partnership with Philips was announced, expected to expand market reach and positively impact medium- to long-term financials.
- Sensor sales showed strong growth, with a 56% increase in TetraSens sensors and a 48% growth in local currencies, highlighting successful product utilization.
- The company secured regulatory approvals from both the FDA and ANVISA, expanding its market presence in the US and Brazil.
- The US market remains challenging, with continued headwinds affecting new monitor sales.
- There was a decline in new TetraGraph monitor shipments compared to the previous year, indicating potential market saturation or competition.
- Macro-economic factors, such as inflation fears, are causing delays in closing big new hospital opportunities.
- Despite improvements, the company still reported a negative EBITDA of SEK17.3 million.
- TIN Ny Teknik fund reduced its shareholding by 1.3 million shares, which could indicate a lack of confidence from investors.
()-
Good morning. Welcome to the presentation of our second-quarter 2026 report here in the midst of Swedish summertime. So the second quarter, a quarter characterized by continued strong growth for our sensors utilization, but continued market headwinds for new monitor sales, specifically in the US market.
So US market has continued to be challenging for us over the last six months. I do note an improvement. But in parallel to this, we've been working diligently on the fundamentals, and I'm happy to report that we have a 15% decrease in our operating expenses. We are reporting a 27% improvement in our EBITDA, and we're reporting a 46% improvement in our cash flow. And this is despite pretty much a zero growth quarter.
So let me come back a little bit more on the numbers and a little bit the background of the business. Okay. So I wanted to comment on the recent announcement of our partnership with Philips. So I'm extremely pleased to announce this. This is the most important commercial agreement that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
